invivodata Recognized as One of Pittsburghâ€™s Fastest Growing Private Companies
CompanyÃ¢s Focus on Delivering Value Contributes to Continued Revenue Growth Rate
Pittsburgh, PA (PRWEB) August 26, 2011
invivodata inc.®, the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, has been recognized in the Ã¢Å“2011 Pittsburgh 100Ã¢ annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania by the Pittsburgh Business Times.
Ã¢Å“We see the Pittsburgh 100 as one of the most important lists we publish,Ã¢ said Alan Robertson, publisher of the Pittsburgh Business Times. Ã¢Å“The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. The Pittsburgh 100 is proof that the region remains a vibrant, growth-oriented business environment.Ã¢
invivodata was named to the annual Pittsburgh 100 based on its revenue growth rate from 2008 through 2010.
Ã¢Å“WeÃ¢re very proud to once again be included in the Pittsburgh 100,Ã¢ said Doug Engfer, invivodata president and CEO. Ã¢Å“The TimesÃ¢ recognition of our continuing growth reflects the impact of our unyielding focus on creating real value for our clients worldwide, employing our innovative and reliable approach to consistently deliver scientifically-proven ePRO solutions, services, and regulatory consulting to our biopharmaceutical customers.Ã¢
invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodataÃ¢s solutions have been used in over 350 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit http://www.invivodata.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/8/prweb8750541.htm